Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Abstract

The update did not identify any relevant studies for Practice Point 2; our previous conclusions are unchanged (1).

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3)

“…The evidence update did not result in any changes to our previous overall assessment, as there continues to be an overall net benefit of remdesivir with both a 5-day course ( 1 , 2 , 8 , 9 ) and a 10-day course ( 1 , 3 , 4 , 8 , 10 ) as well as evidence suggesting that 5 days of treatment may be as effective as 10 days ( 1 , 8 ).…”